Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Ovarian Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Neoplasms 1Kidney Neoplasms 1Esophageal Neoplasms 1

Interventions

Paclitaxel 326Carboplatin 318Bevacizumab 167Gemcitabine 106pembrolizumab 100liposomal doxorubicin 100Cyclophosphamide 94Topotecan 93Cisplatin 89olaparib 86niraparib 60Docetaxel 56Taxes 52Doxorubicin 50Drug Therapy 42fludarabine 39Filgrastim 39Nivolumab 37Etoposide 32Specimen Handling 31Magnetic Resonance Spectroscopy 29Immunoglobulin G 27Disulfides 27Peripheral Blood Stem Cell Transplantation 26Albumin-Bound Paclitaxel 25durvalumab 24aldesleukin 24Hyperthermic Intraperitoneal Chemotherapy 24Oxaliplatin 23Biopsy 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Ovarian Neoplasms × Histocompatibility Testing × Clear all
NCT06084195 2025-02-12

MR-O-MICS

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting
120 enrolled
Gynecologic

Ovarian Neoplasms

NCT06144762 2025-02-12

PANC-O-MICS

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting
150 enrolled
GastrointestinalGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡